Scribe Therapeutics Inc.

Direct answer

Scribe Therapeutics Inc. is publicly traded on NASDAQ under the ticker SCTX.

Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.

Can you invest in Scribe Therapeutics Inc.?

Yes. Scribe Therapeutics Inc. is publicly traded on NASDAQ under the ticker SCTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Scribe Therapeutics Inc.

Detailed equity research is provided by MarketSnap.